Objective: We compared aortic stiffness between HIV-infected and HIV-uninfected
individuals and examined the determinants of vascular aging during HIV infection. Methods …

Background: Patients with HIV, even with suppressed viremia on combination antiretroviral
therapy, are at increased risk for cardiovascular disease. The underlying pathophysiology …

Increased aortic stiffness is an important predictor of cardiovascular disease (CVD). It
remains controversial whether HIV infected persons have increased aortic stiffness at the …

HIV infection is associated with chronic immune activation, subclinical inflammation, and an
atherogenic metabolic profile. It remains controversial whether HIV infection is a risk factor …

People living with human immunodeficiency virus (HIV) infection and receiving antiretroviral
therapy now have the same life expectancy as the general population. However, they have a …

Background Human immunodeficiency virus (HIV) infection is associated with a greater risk
of cardiovascular disease (CVD). HIV infection causes a chronic inflammatory state and …

BACKGROUND: Human immunodeficiency virus (HIV) infection is associated with
subclinical inflammation and increased cardiovascular risk. Arterial stiffness and enhanced …

Abstract Background The risk of Cardiovascular (CV) events is higher in HIV-infected
patients (HIV+) compared to HIV-uninfected persons (HIV−). Large artery stiffness, a well …

The human immunodeficiency virus (HIV) epidemic has been a scientific challenge for over
35 years, and despite great strides forward, there is still no cure or proven vaccination …

Background—The role of antiretroviral therapy in acceleration of atherosclerosis in patients
with human immunodeficiency virus (HIV) infection is controversial. We hypothesized that …